The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16(INK4a) gene in acute type adult T-cell leukemia

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 51-56

  Hori, Yasuko ^a,d   Hori, Hiroki ^a   Yamada, Yasuaki ^b   Carrera, Carlos J ^a   Tomonaga, Masao ^b   Kamihira, Shimeru ^c   Carson, Dennis A ^a   Nobori, Tsutomu ^a  

^a San Diego   (United States)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DERIVATIVE; PHOSPHORYLASE;

ARTICLE; CHROMOSOME 9P; EXON; GENE DELETION; GENE LOCATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; LEUKEMOGENESIS; ONSET AGE; PRIORITY JOURNAL; SOUTHERN BLOTTING; T CELL LEUKEMIA;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LEUKEMIA, T-CELL; MIDDLE AGED; PURINE-NUCLEOSIDE PHOSPHORYLASE;

EID: 0032484510     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<51::AID-IJC9>3.0.CO;2-0     Document Type: Article

References (22)

1. BATOVA, A., DICCIANNI, M.B., NOBORI, T., VU, T., YU, J., BRIDGEMAN, L. and YU, A., Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy. Blood, 88, 3083-3090 (1996).
2. INK4, methylthioadenosine phosphorylase, and the α and β-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Cancer Res., 56, 1083-1090 (1996).
3. GILL, P.S. and 12 OTHKRS, Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N. Engl. J. Med., 332, 1744-1748 (1995).
4. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood, 87, 4949-4958 (1996).
5. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371, 257-261 (1994).
6. HATTA, Y., HIRAMA, T., MILLER, C.W., YAMADA, Y., TOMONAGA, M. and KOEFFLER, H.P., Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood. 85, 2699-2704 (1995).
7. HORI, H., TRAN, P., CARRERA, C.J., HORI, Y., ROSENBACH, M.D., CARSON, D.A. and NOBORI, T., Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells. Cancer Res., 56, 5653-5658 (1996).
8. IMADA, K., TAKAORI-KONDO, A. and UCHIYAMA, T., Analysis of in vivo cell proliferation of ATL using SCID mice. Jpn. J. clin. Hematol., 36, 573-577 (1995).
9. KAMATANI, N., NELSON-REES, W.A. and CARSON, D.A., Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proc. nat. Arad. Sci. (Wash.), 78, 1219-1223 (1981).
10. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264, 436-440 (1994).
11. LYMPHOMA STUDY GROUP, Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leukemia Res., 15, 81-90 (1991).
12. NOBORI, T., KARRAS, J.G., DELLA RAGIONE, F., WALTZ, T.Z., CHEN, P.P. and CARSON, D.A., Absence of methylthioadenosine phosphorylase in human gliomas. Cancer Res., 51, 3193-3197 (1991).
13. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D. A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
14. NOBORI, T., SZINAI, I., AMOX, D., PARKER, B., OLOPADE, O.I., BUCHHAGEN, D.L. and CARSON, D.A., Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res., 53, 1098-1101 (1993).
15. NOBORI, T., TAKABAYASDHI, K., TRAN, P., ORVIS, L., BATOVA, A., YU, A.L. and CARSON, D.A., Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc. nat. Acad. Sci. (Wash.), 93, 6203-6208 (1996).
16. POMYKALA, H.M., BOHLANDER, S.K., BROEKER, P.L., OLOPADE, O.I. and DIAZ, M.O., Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol. cell. Biol., 14, 7604-7610 (1994).
17. SATO, N., IWATA, S., YAMAUCHI, A., HORI, T. and YODOI, J., Thiol compounds and adult T-cell leukemia virus infection: a potential therapeutic approach. Methods Enzymol., 252, 343-348 (1995).
18. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
19. SHIMOYAMA, M., Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Brit. J. Haematol., 79, 428-437 (1991).
20. INK4A and counteracts its inhibitory activity towards CDK4. EMBO J., 15, 1607-1614 (1996).
21. TRAN, P.T., HORI, H., HORI, Y., OKUMURA, K., KAGOTANI, K., TAGUCHI, H., CARSON, D.A. and NOBORI, T., Molecular cloning of the human methylthioadenosine phosphorylase processed pseudogene and localization to 3q28. Gene. 186, 263-269 (1997).
22. YAMADA, Y., NAGATA, Y., KAMIHIRA, S., TAGAWA, M., ICHIMARU, M., TOMONAGA, M. and SHIKU, H., IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells, Leukemia Res., 15, 619-625 (1991).